Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00111371
Status:
UNKNOWN
Last Update Posted:
2014-12-05
First Post:
2005-05-19
Brief Title:
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia
Sponsor:
University Hospital Muenster
Organization:
University Hospital Muenster
Study Overview
Official Title:
Dopaminergic Enhancement of Learning and Memory LL_001 Project on Dyslexia
Status:
UNKNOWN
Status Verified Date:
2006-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to determine whether levodopa in combination with a high frequency training of grammatical rules is effective in boosting learning success in healthy subjects and whether this kind of training in combination with levodopa improves reading and spelling abilities of patients with dyslexia
Detailed Description:
Prior work by our group shows that d-amphetamine and the dopamine precursor levodopa markedly improve word learning success in healthy subjects In this randomized placebo-controlled double-blind trial we probe whether daily administration of levodopa coupled with a training of grammatical rules improves the training success in healthy adults as compared to placebo administration In the second step of this study patients with dyslexia will be trained with the identical protocol We postulate that the combination of intensive training in language rules and levodopa improves the reading writing and spelling abilities of patients with dyslexia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None